APA (7th ed.) Citation

Averna, M., Banach, M., Bruckert, E., Drexel, H., Farnier, M., Gaita, D., . . . Catapano, A. L. (2021). Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force. Atherosclerosis, 325, . https://doi.org/10.1016/j.atherosclerosis.2021.03.039

Chicago Style (17th ed.) Citation

Averna, Maurizio, et al. "Practical Guidance for Combination Lipid-modifying Therapy in High- and Very-high-risk Patients: A Statement from a European Atherosclerosis Society Task Force." Atherosclerosis 325 (2021). https://doi.org/10.1016/j.atherosclerosis.2021.03.039.

MLA (9th ed.) Citation

Averna, Maurizio, et al. "Practical Guidance for Combination Lipid-modifying Therapy in High- and Very-high-risk Patients: A Statement from a European Atherosclerosis Society Task Force." Atherosclerosis, vol. 325, 2021, https://doi.org/10.1016/j.atherosclerosis.2021.03.039.